GPT-Rosalind (OpenAI) vs Nemotron (Nvidia)

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Nemotron (Nvidia)

B
7.8/10

Nvidia's open-weights family -- hybrid Mamba-Transformer MoE architecture, optimized for efficient reasoning on Nvidia hardware

CategoryGPT-Rosalind (OpenAI)Nemotron (Nvidia)
Ease of Use3.06.5
Output Quality9.08.0
Value7.08.0
Features8.08.5
Overall6.87.8

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Nemotron (Nvidia)
Free TierNoYes
Starting PriceInvite only$0

Benchmark Head-to-Head

Nemotron 3 Ultra (253B) benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks

BenchmarkScore
MMLU-Pro79.8%
GPQA Diamond70.5%
AIME 202584.5%
HumanEval89.6%
MMLU (Llama-Nemotron 70B)88.4%

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

  • Higher output quality (9 vs 8)

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Nemotron (Nvidia) if...

  • Easier to use (6.5 vs 3)
  • Better value for money (8/10)
  • Has a free tier

Teams running on Nvidia hardware (TensorRT-LLM, NIM) who need efficient long-context reasoning. Nemotron 3 Super is a standout for its 8 GB VRAM footprint with strong reasoning.

Visit Nemotron (Nvidia)

Our Verdict

Nemotron (Nvidia) is the clear winner here with 7.8/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Nemotron (Nvidia) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.